Demand for weight-loss drugs is rising at a fast clip in India, where rivals Eli Lilly and Novo Nordisk are competing for ...

Cipla is set to enter India's weight management market, addressing the increasing demand for obesity solutions, while also ...

Mumbai: Mumbai-based pharma giant Cipla is gearing up to make an entry into India's rapidly growing weight management market, ...

Demand for weight-loss drugs is rising at a fast clip in India where rivals Eli Lilly and Novo Nordisk are competing for ...

Cipla Limited is planning to enter the weight management segment in India, announced the company’s MD and global CEO Umang ...

Pharmaceutical giant Cipla plans to enter India's weight management sector, while also bolstering its central nervous system ...

New Delhi: Drug major Cipla is preparing to foray into the weight management segment in India, its MD and global CEO Umang ...

The health sector is witnessing notable developments, including the rising demand for obesity drugs in India as Eli Lilly and ...

Incidence of obesity and diabetes is rising in India, the world's most populous country, which also ranks among the worst ...

Drug major Cipla, led by MD and CEO Umang Vohra, is entering India's weight management segment and strengthening its CNS ...

Sales of Eli Lilly’s Mounjaro double in a month; Novo Nordisk’s Wegovy enters market amid rising obesity and diabetes rates.

STORY: :: Eli LillyDemand for weight-loss drugs in India has shot up.And rivals Novo Nordisk and Eli Lilly are battling for market share.That’s according to research firm Pharmarack.It said ...